Ethical Compliance
SEQUENT SCIENTIFIC.
Sector:
Healthcare
Industry:
Drug Manufacturers - Specialty & Generic
Market Cap Class:
small
Revenue
16%
Debt
3.9%
Liquidity
0.1%
Revenue
Debt
Liquidity
16%
Non Compliant
Questionable
Compliant
Compliant
INR Crores
| Bulk drugs | ₹157.71 |
| Other Operating Revenue | ₹10.81 |
| Other Income | ₹11.59 |
Questionable
INR Crores
Non Compliant
INR Crores
| Interest Income | ₹34.39 |
INR Crores
| Revenue from Questionable Sources: | ₹0.00 |
| Revenue from Non Compliant Sources: | ₹34.39 |
| Total: | ₹34.39 |
| Total Revenue: | ₹214.50 |
Formula
Revenue from Questionable & Non Compliant Sources
Total Revenue
≤ 0.03 or 3%
Calculation
₹34.39
₹214.50
= 16%
non-compliant
Rationale
The sum of revenue from questionable and non-compliant sources should not exceed 3% of the total revenue. This ensures that the company has tolerable reliance on unethical sources of revenue.
